716. A randomised-controlled feasibility study of ketamine for the treatment of depression with anorexia nervosa
International Journal of Neuropsychopharmacology September 9, 2026 J Keeler, H Himmerich, J Treasure et al.
Abstract Background Approximately a third of people with anorexia nervosa (AN) develop a severe and enduring form of the illness, which is often accompanied by depression. This can be a key barrier to recovery. Anti-depressant medications are less effective in treating depression in patients with acute AN, thus new pharmacological treatment options are needed. Ketamine is currently used for...